Antimicrobial activities of seven novel tetramethylpiperidine-substituted phenazines against multiple-drug-resistant gram-positive bacteria

Chemotherapy

Volumn 51, Issue 5, 2005, Pages 263-267

  Huygens, Flavia ^a,c   O'Sullivan, John F ^b   Van Rensburg, Constance E J ^a  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Antibacterial activity; Gram positive bacteria; Phenazines; Riminophenazines; Tetramethylpiperidine

Indexed keywords

B 4100; B 4103; B 4119; B 4121; B 4125; B 4126; B 4163; CLOFAZIMINE; PHENAZINE; PIPERIDINE DERIVATIVE; UNCLASSIFIED DRUG;

AGAR GEL DIFFUSION; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL INFECTION; BACTERIUM ISOLATE; CONTROLLED STUDY; ENTEROCOCCUS FAECIUM; GRAM POSITIVE BACTERIUM; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MORBIDITY; MORTALITY; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIA;

CLOFAZIMINE; DRUG RESISTANCE, MULTIPLE; ENTEROCOCCUS; LEPROSTATIC AGENTS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; PHENAZINES; PIPERIDINES; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 23944437378     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087454     Document Type: Article

References (16)

1. Adam D: Global antibiotic resistance in Streptococcus pneumoniae. J Antimicrob Chemother 2002;50(suppl):1-5.
2. File TM: New insights in the treatment by levofloxacin. Chemotherapy 2004; 50(suppl 1):22-28.
3. Kimura T, Horii T, Morita M, Muramatsu H, Kanno T, Maekawa M: Detection of macrolide resistance in Streptococcus pneumoniae. Chemotherapy 2003;49:56-61.
4. Pallares R, Biladrich PF, Linares J, Cabellos C, Gudiol F: Impact of antibiotic resistance on chemotherapy for pneumococcal infections. Microb Drug Resist 1998;4:339-347.
5. Huycke MM, Sahm DF, Gilmore MS: Multiple-drug resistant enterococci: The nature of the problem and an agenda for the future. Emerg Infect Dis 1998;4:239-249.
6. Centers for Disease Control: Proportion of S. aureus nosocomial infections resistant to oxacillin (MRSA) among intensive care unit patients, 1989-2003. National Nosocomial Infections Surveillance (NNIS) System, 2003.
7. Khare M, Keady D: Antimicrobial therapy of methicillin resistant Staphylococcus aureus infection. Expert Opin Pharmacother 2003;4:165-177.
8. Barry VC, Belton JG, Conalty ML, Denneny JM, Edwart DW, O'Sullivan JF, Twomey D, Winder F: A new series of phenazines (rimino-compounds) with high antituberculosis activity. Nature 1957;179:1013-1015.
9. Browne SG: Treatment of leprosy with B663. Appraisal of the pilot trial after three years. Lepr Rev 1965;36:13-15.
10. Atkinson AJ, Shaegren JN, Rubio JB, Knoght V: Evaluation of B663 in human leprosy. Int J Lepr 1967;35:119-127.
11. World Health Organization: Chemotherapy of leprosy for control programmes. World Health Organ Tech Rep Ser 1982;675:1-33.
12. van Niekerk S, Huygens F, van Rensburg CEJ: A time-kill study to evaluate the in-vitro activity of clofazimine in combination with cefotaxime against a penicillin- and cefotaxime-resistant strain of Streptococcus pneumoniae. J Antimicrob Chemother 1997;40:602-604.
13. Oliva B, O'Neill AJ, Miller K, Stubbings W, Chopra I: Anti-staphylococcal activity and mode of action of clofazimine. J Antimicrob Chemother 2004;53:435-440.
14. Franzblau SG, White KE, O'Sullivan JF: Structure-activity relationships of tetramethylpiperidine-substituted phenazines against Mycobacterium leprae in vitro. Antimicrob Agents Chemother 1989;33:2004-2005.
15. van Rensburg CEJ, Joone GK, Sirgel FA, Matlola NM, O'Sullivan JF: In vitro investigation of the antimicrobial activities of novel tetramethylpiperidine-substituted phenazines against Mycobacterium tuberculosis. Chemotherapy 2000;46:43-48.
16. National Committee for Clinical Laboratory Standards: Performance Standards for Antimicrobial Susceptibility Testing - Thirteenth Informational Supplement M7-A6. Villanova, NCCLS, 2003.